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Abstract 
The present case study is on a 16-year-old
woman who was suffering from nephrotic syn-
drome  after  recovery  from  complete  type  of
hydatiform mole. She was admitted in hospital
because  of  proteinurea  and  hematuria.  Then
she was showing a generalized edema compati-
ble with neprhotic syndrome. In her past med-
ical  history  she  had  a  suction  curettage  for
hydatiform mole. After she received 4 courses
chemotherapy,  she  completely  recovered  and
ʲhCG has fallen from 12127 IU/L to under 10
IU/mL.  Then  she  showed  generalized  edema,
proteinurea  and  hematuria  compatible  with
nephritic syndrome. After six courses chemo  -
therapy the symptoms of nephrotic syndrome
and  invasive  mole  diminished,  she  released
from hospital and scheduled for follow-up. 
Introduction
During normal pregnancy, the maximum of
urinary protein excretion ranges from 200-300
mg per day. Nephrotic syndrome in pregnancy
is  very  rare.
1 The  most  common  cause  is
preeclampsia  associated  with  preeclamptic
nephropathy. Preeclampsia may have a rela-
tion to the molar pregnancy. Twelve percent of
molar  pregnancies  are  associated  with
preeclampsia.
2 We report a case of nephrotic
syndrome  associated  with  complete  type  of
hydatiform mole. 
Case Report
Diagnosis and treatment of the
hydatiform mole
A 16-year-old Iranian woman, gravid 1, para
1 was admitted to the Educational hospital of
Razi in gynecologic section because of molar
pregnancy  in  4/2/2010.  In  admission  time
uterine size was 16 weeks of pregnancy, uter-
ine  sonogram  showed  enlarged  uterus  con-
tained 400 mL cystic tissue compatible with
molar pregnancy or missed abortion. 
Suction curettage was done and vesicular
tissue has sent for pathologic study. Pathology
result  revealed  molar  pregnancy  (6/2/2010)
(Figure 1). At that time laboratory investiga-
tion showed: ʲhCG: 1980 IU/mL, total blood
count  showed;  hemoglobin  (Hb):  10.8  g/dL,
white blood cell (WBC): 10.8ﾥ109/L, platelets:
247ﾥ109/L, blood glucose: 82 mg/dL, liver func-
tion and thyroid function tests were normal.
Two days after suction curettage the patient
was discharged and scheduled for follow-up of
molar  pregnancy  (weekly  measurement  of
ʲhCG).
Diagnosis and treatment of the
nephrotic syndrome
About  two  months  later  in  28/3/2010  the
patient admitted in the nephrology ward in the
educational  hospital  of  Imam  Khomaini
because  of  generalized  edema  (she  did  not
measure ʲhCG in a regular time). On exami-
nation blood pressure was 120/60 mmHg with
a regular heart rate of 80 per minute, a para-
tibia  pitting  edema  (2+)  was  noted.  The
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Table 1. Paraclinical tests in the patient sus-
pected to the nephrotic syndrome.  
Tests Results
Urinalysis 
Proteinuria  4+
Red blood cell in high power fields  10-12
Hemoglobin  1+
WBC in high power field  8-10
24 urinary protein exertion 9400 mg
Liver function tests 
SGOT 24 µg/L
SGPT 22 µg/L
Bilirubin 0.8 mg/dL
Partial thromboplastin time 30 sec
Prothrombin activity  81%
Total blood count test
Hemoglobin 13 g/dL
WBC ×1000/mm3 11.6 
Platelets ×1000/mm3 270 
Blood urea nitrogen  7 mg/dL
Creatinin  0.7 mg/dL
Sodium 139 mg/L
Potassium 4.2 mg/L
Calcium 8/9 mg/dL
Phosphorous  4.6 mg/dL
Table  2.  Paraclinical  tests  in  the  patient  sus-
pected to the nephrotic syndrome.   
Blood tests for lipid Results 
and antibodies 
Total cholesterol  322 mg/dL
Triglycerids 393 mg/dL
High density lipoprotein 33 mg/dL
Low density lipoprotein 270 mg/dL
Very low density lipoprotein 18 mg/dL
International ratio 1.1
Erythrocyte sedimentation rate  52 mm/hr
C-reactive protein 3+
Complement component 3 150 mg/dL 
(86-184 mg/dL)
Complement component  20.3 mg/dL
(20-57 mg/dL)
The dose of complement that 94 U/mL 
lyses 50% of a red cell suspension (63-184 U/mL) 
Glomerular basement membrane Negative
Antinuclear antibody test 1/40
Protoplasmic-staining anti- <1.4 U mL
neutrophil cytoplasmic antibodies 
Classical antineutrophil   Negative (normal
cytoplasmic antibodies  <2.8 U/mL)
Antids-DNA 1/10
Antiphospholipid  5.1 mg/dL
(immunoglobolin G antibodies) 
Immuunoglobolin M antibodies 3 mg/dL (0-15 mpl)[Rare Tumors 2010; 2:e61] [page 175]
results of paraclinical tests are presented in
Table 1 and 2. Pelvic sonogram was normal.  In
ultrasound scan the size of the kidneys was
111 mm with normal echo texture. The patient
did not get consent for kidney biopsy. 
Treatment started with oral prednisolon 50
mg,  oral  calcium  daily,  omperazol  cap  20
mg/day, frusemide 40 mg daily. The low salt
diet and restriction of fluid have chosen for
her. In respect to past medical history, gyne-
cology consultation has done and she referred
to gynecologic section. 
The  urinalysis  showed;  proteinuria  (3+),
10-12 red blood cells in high power field, WBC
30-35.  ʲhCG  titer  raised  to  12127  U/mL
(21/3/2010),  nephrotic  syndrome  associated
with  invasive  mole  was  suggested  and
chemotherapy was started at (25/3/2010) with
methotrexate (MTX). After she took six cours-
es of chemotherapy, ʲhCG decreased to the
normal  range.  The  process  of  reduction  of
ʲhCG is demonstrated in Table 3. After che  -
mo  therapy,  24  h  urinary  protein  exertion
decreased from 9400 mg to 380 mg. At this
time pelvic ultrasound scan was normal. Six
weeks  after  treatment  the  patient  was  well
enough to discharge from hospital and sched-
ule for follow-up.
Discussion
In  this  young  patient  with  generalized
edema, history of hydatiform mole and high
ʲhCG, treatment with chemotherapy was start-
ed. There was no evidence of recurrence or
metastasis of mole and she remained in com-
plete  remission  of  nephrotic  syndrome  after
chemotherapy. Nephrotic syndrome occurs in
0.012-0.025%  of  all  pregnancies.
3 The  usual
causes are preeclampsia, glomerulonephritis,
diabetes,  renal  vein  thrombosis,  amyloidosis
and  hereditary  nephritis.  Occasionally  it  is
necessary to treat the nephrotic syndrome with
steroids.  There  is  no  proper  response  to
steroids  which  can  aggravate  the  problems
related  to  nephrotic  syndrome.  Thus,  it  is
important to know about histology before start-
ing treatment.
2 Urinary protein excretion 200-
300 mg per day is normal during pregnancy.
4
Preeclamptic  nephropathy  is  about  80%  in
nephrotic syndrome during pregnancy. Other
cases occur because of membranous nephro  -
pathy,  focal  glumerulosclerosis,  minimal
change  nephropathy,  diabetic  nephropathy,
systemic lupus erythematosus and other renal
diseases.
4 The  renal  pathologic  feature  in
preeclamptic  nephropathy  is  bloodless
glomerular  enlargement  and  the  narrowing
the  capillary  lumen  due  to  swelling  of  the
endothelial, mesential and epithelial cells with
an  expansion  of  the  mesential  matrix.  The
glomerular  capillary  walls  may  be  thickened
but  hypercellular  change  rarely  occurs.
5-9
Akhtars case was a preeclamptic nephropathy
associated with a partial mole with a coexis-
tent fetus.
3 In the Cohen's case they did not
performed renal biopsy but the nephritic syn-
drome was clinically related to a preeclamptic
nephropathy. In this case, the hydatiform mole
was incomplete type coexisting fetal tissue.
10
Komatsuda reported an older patient revealed
a membrano proliferative like lesion by renal
biopsy.  His  case  was  a  nephrotic  syndrome
associated with a complete type of hydatiform
mole.
11 Prior to this report, there was a similar
case reported in Korean journal.
12 Han report-
ed a 54-year old patient with membrano prolif-
erative  glumeronephritis  associated  with  a
complete type of hydatiform mole that patient
remained renal symptom free for 2 year after
the  removal  of  the  tumor.
5 In  our  case,  the
hydatiform mole was a complete type and renal
biopsy was not performed. The precise rela-
tionship  between  the  hyditiform  mole  and
nephrotic syndrome is not clear, because the
reported cases were extremely rare. The pro-
duction of immune complexes and the activa-
tion of intravascular coagulation by the hydat-
iform mole are the supposed pathogenic mech-
anism.
3 These several interesting cases link-
ing the pathogenesis of the glomerulonephri-
tis directly to the gestational trophoblastic dis-
ease provide a challenge for future research.
Conclusions
The hydatiform mole might be a cause of the
nephrotic syndrome in some cases. Precise fol-
low-up  after  molar  pregnancy  may  help  the
specialists for early reorganization of rare sit-
uations. 
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Case Report
Table 3. Reduction of βhCG after chemotherapy.
Weeks of treatment  ʲhCG (U/mL)
In time of diagnosis of  12127
nephrotic syndrome
1stweek after chemotherapy 17124 
2ndweek after chemotherapy 4370 
3rdweek after chemotherapy 687 
4thweek after chemotherapy  67 
5thweek after chemotherapy  <10 
6thweek after chemotherapy  <10
Figure  1.  Photomicrograph  of  complete
mole;  multiple  large  villi  show  stromal
edema and marked trophoblastic prolifera-
tion.